ITGAM and neoplasm: On treatment with metformin we observed a small, nonsignificant decrease in tumor vascularity (vessel area: μm2/hpf; Fig. 12A–C) and a small, nonsignificant decrease of infiltration by CD11b cells [CD11b(+) cells/DAPI(+) cells Fig. 12D–F].